Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04998188

Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis

The aim of the study is to compare the 6 months clinical outcome of the treatment with a single intra-articular collagen injection versus a single placebo (saline solution) infiltration in the infiltrative treatment of knee osteoarthritis. The evaluation will be performed through clinical, subjective and objective assessments.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

204 patients affected by knee osteoarthritis will be included in a double-blinded randomized controlled trial. Patients in the experimental group will be treated with a single intra-articular injection of collagen (solution of low molecular weight peptides derived from hydrolyzed collagen) instead patients in the control arm, will be treated with a single intra-articular injection of placebo (saline solution). All patients will be evaluated by clinical examination before the infiltrative procedure and they will follow-up at 1,3,6 months. During the follow-up visits ,will be evaluated the inflammatory status of the knee by thermographic assessment and questionnaires, filled out by patients, will be utilized for clinical evaluations. After 6 months, patients in the control arm (saline solution injection), have the possibility to cross-over into the treatment arm (collagen) in which case they will be followed for an additional 6 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unilateral involvement;
  • Signs and symptoms of degenerative pathology of knee cartilage;
  • Radiographic and MRI signs of degenerative pathology of the knee cartilage (Kellgren-Lawrence 1-4 grades);
  • Failure, defined as the persistence of symptoms, after at least one course of conservative treatment (pharmacological, physiotherapeutic or infiltrative treatment);
  • Ability and consent of patients to actively participate in clinical follow-up;

Exclusion criteria

  • Patients who have undergone intra-articular injections of another substance in the previous 6 months;
  • Patients undergoing knee surgery within the previous 12 months;
  • Patients with malignant neoplasms;
  • Patients with rheumatic diseases;
  • Patients with diabetes;
  • Patients with hematologic diseases (coagulopathies);
  • Patients on anticoagulant therapy;
  • Patients with metabolic disorders of the thyroid gland;
  • Patients abusing alcoholic beverages, drugs or medications;
  • Body Mass Index > 35;
  • Pregnant or lactating women.
  • Patients with established hypersensitivity to bovine collagen or vitamin C.
  • Patients with joint or peri-articular infections, emarto, erythema, or psoriatic patches in the knee joint area

Treatment and study plan

Collagen

Procedure

Patients will be treated with a single injection of collagen (2 ml) in the knee joint affected by osteoarthritis

Placebo (saline solution)

Procedure

Patients will be treated with a single injections of saline solution (2 ml) in the knee joint affected by osteoarthritis

Primary outcomes

  1. KOOS-Pain Score

    Time frame: 6 months follow-up

    KOOS-Pain Score is referred to a subscale of pain composed by 9 items. The score range considerate is 0-100.The score uses a 5-point Likert scale and each question is assigned a score from 0 to 4, where 0 indicates "no pain" and 4 "severe level of pain"

Secondary outcomes

  1. IKDC-Subjective Score

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    This is a subjective, knee-specific rating scale that is considered one of the most reliable assessment tools in the evaluation of knee pathologies. All questions examines 3 categories: symptoms, sports activity, and knee function

  2. KOOS Score

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    KOOS SCORE consists of 5 subscales and covers: pain (9 items), symptoms (7 items, two of which are related to stiffness), functions and activities of daily living (17 items), physical function, sports and leisure activities (5 items) and quality of life in relation to the knee (4 items).

    Each question is scored from 0 to 4, where 0 indicates "no difficulty" and 4 "severe difficulty. Score range 0-100 for each subscale

  3. WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score

    Time frame: baseline, 1 month, 3 months, 6 and 12 months follow-up

    It's a standardized questionnaire to assess the condition of patients affected by knee osteoarthritis and includes assessment of pain, stiffness and physical functioning of the joints. It measures 5 items for pain (range 0-20), two for stiffness (range 0-8) and 17 for functional limitation (range 0-68) that relate mainly to activities of daily living. The score is normalized on a 0-100 scale. Higher values indicate a worse outcome.

  4. VAS-pain (Visual Analogue Scale)

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    VAS is a visual analogue scale consisting of a range scale (10 cm length), the ends of which correspond to "no pain" and "the strongest pain imaginable".

  5. EQ-VAS

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    EQ-VAS Is a visual analog scale that has a range of scores from 0 (worst imaginable health condition) to 100 (best imaginable health condition).

  6. EQ-5D (EuroQoL) Current Health Assessment

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    The EQ-5D profile, asks patients to classify their health based on self-assessed levels of problems ("no", "some", "extreme") on five dimensions.

  7. TegnerActivity Level Scale

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    Tegner activity level scale allows to know the level of physical activity carried out by the patients. Tegner's activity scale classifies the activity according to work and sports activities on a scale from 0 to 10. Zero represents disability because of knee problems and 10 represents soccer a national or international level

  8. Patient Acceptable Symptom State (PASS)

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    A tool to assess patient satisfaction in consideration of their current degree of pain, function, and daily activity. Patients can express if their state of health will be satisfying, answering "yes" or "no".

  9. Objective parameters -Range of motion

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    Evaluation of the Range of Motion for comparative analysis.

  10. Final treatment opinion

    Time frame: 6 months follow-up

    The patient should indicate satisfaction and relative degree with treatment at the end of the clinical trial (24 months follow-up). All patients will be able to indicate their health condition by choosing from this answers; "Full recovery", "much better", "somewhat better", "no change", "a little worse", "much worse".

  11. Ultrasound assessment

    Time frame: Baseline

    This examination is useful to do an initial assessment of possible meniscal extrusion in the interested knee joint.

  12. Thermographic evaluation of the inflammatory status of the knee joint

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    The evaluation will be performed through the use of a thermal imaging camera. The thermal camera will allow to detect even small variation of knee temperature thus comparing and recording any thermographic changes in the inflammatory state of the joint before and after treatment.

  13. Objective parameters - Circumferences

    Time frame: baseline, 1 month, 3 months, 6 months follow-up

    Bilateral trans- and supra- patellar circumferences measurement for comparative analysis

Study contacts

Contact information is provided by the study sponsor or research team.

Alessandro Di Martino, MD

CONTACT

[email protected]

Roberta Licciardi, Msc

CONTACT

[email protected]

0516366567

Sponsors and collaborators

Lead sponsor

Istituto Ortopedico Rizzoli

Other

Registry information

Official study title

Hydrolyzed Collagen Formulation Versus Placebo in the Treatment of Degenerative Knee Cartilage Injuries

Important dates

Study start
2022
Primary completion
2027
Study completion
2027
First posted
Aug 10, 2021
Registry last updated
Feb 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.